Genmab A/S — 105 Patents, Ranked #6,646

Patents per Year

Showing 1–50 of 142 inventors

Rank	Name	Patents
1	Paul Parren	78
2	Jan Van De Winkel	47
3	Janine Schuurman	42
#4	David Satijn	32
#5	Aran Frank Labrijn	29
#6	Ole Baadsgaard	28
#7	Edward Norbert Van Den Brink	25
#8	Bart DE GOEIJ	16
#9	Isil Altintas	15
#9	Joyce I. Meesters	15
#9	Joost J. NEIJSSEN	15
#9	Rik RADEMAKER	15
#9	Tom Vink	15
#14	Esther BREIJ	14
#15	Arnout Gerritsen	13
#15	Ugur Sahin	13
#17	Friederike Gieseke	12
#17	Jørgen Petersen	12
#17	Patrick Van Berkel	12
#20	Rene Hoet	10
#21	Dennis VERZIJL	9
#21	Marcus A. van Dijk	9
#23	Sandra VERPLOEGEN	8
#24	Patrick ENGELBERTS	7
#24	Rob N. De Jong	7
#24	Willem Karel Bleeker	7
#27	Ewald T. J. Van Den Bremer	6
#27	Jessica Teeling	6
#27	Michel DE WEERS	6
#30	Brian Elliott	5
#30	Catharina Emanuele Gerarda Havenith	5
#30	Denise Williams	5
#30	Riemke VAN DIJKHUIZEN RADERSMA	5
#30	Simone De Haij	5
#30	Steen LISBY	5
#30	Tahamtan Ahmadi	5
#30	Thilo Riedl	5
#30	Yvo Graus	5
#39	Alexander Muik	4
#39	Christopher Chiu	4
#39	Debra Hudson	4
#39	Edward L. Halk	4
#39	Jorgen Petersen	4
#39	Kristel Kemper	4
#45	Frank BEURSKENS	3
#45	Ida HIEMSTRA	3
#45	Judith OPRINS	3
#45	Maria Jure-Kunkel	3
#45	Martine Van Vugt	3
#45	Richard HIBBERT	3

Patent	Est. Value	Year
Nucleic acid molecules encoding binding agents to CD40 and 4-1BB (CD137)	$82M	2023
Monoclonal antibodies directed against programmed death-1 protein and their use in medicine	$73M	2024
Human monoclonal antibodies against interleukin 8 (IL-8)	$15M	2007
Bispecific antibodies against HER2 and CD3	$14M	2023
Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma	$13M	2023